Success Stories: NIW Confirmation Received for a Bioinformatics Scientist from Turkey, Thanks to Our Team’s Constant Efforts

Client’s Testimonial:

“Thank you very much for your help in preparing my case.”

On May 26^th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Bioinformatics Scientist in the Field of Bioinformatics (Approval Notice).

General Field: Bioinformatics

Position at the Time of Case Filing: Bioinformatics Scientist

Country of Origin: Turkey

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: May 26^th, 2022

Processing Time: 15 months, 2 days

Case Summary:

A bioinformatics scientist from Turkey came to us for her NIW (National Interest Waiver) application. Her proposed endeavor was to work on her research on large-scale genetics and bimolecular datasets to discover disease-driver mechanisms and identify therapeutic targets. This would have helped to develop personalized, cost-effective diagnostics and therapies for diseases such as cancer, including myeloma. Among other applications, her research is relevant to treating myeloma, reducing the cost of healthcare, and enhancing the quality of diagnostics. Thus her research is clearly of great importance because it improves the global effort to effectively diagnose and treat diseases, especially myeloma.

Our client has greatly advanced the fight against myeloma through her research on protein functionality, genomes and phenotypes, and protein discovery, as well as her ongoing research into therapeutic outcomes in patients with multiple myeloma. She has thus asserted herself as a globally essential researcher who has invaluably improved disease diagnostics and therapeutics, including myeloma. This is why her work has been appreciated by several other scholars of which 4 scholars gave her letters of recommendation. One of these recommendations read:

“[The client] is conducting research of truly global importance, as her work addresses both of these priorities. Specifically, she is training algorithms to assess and differentiate data on myeloma in order to significantly increase the accuracy of diagnosis. Furthermore, she is also training algorithms to analyze genetic data in order to identify individualized therapeutic targets and deliver therapeutic treatments at reduced cost and greater efficacy.”

At the same time, her proposed endeavor also has broad implications for the United States, since the US healthcare system currently suffers from many issues, including increasingly prohibitive pricing and imprecise diagnostics. Our client is addressing both of these issues in her research on advancing therapeutics and diagnostics for diverse conditions, including cancer.

Thus, due to its evident national importance, her research has also been supported with funding from the National Science Foundation (NSF), the National Institutes of Health (NIH), and the National Aeronautics and Space Administration (NASA).

At the same time, she has completed at least 16 reviews to date and her research has resulted in 5 peer-reviewed journal articles (2 of them first-authored) and 2 conference papers which have been cited a total of 139 times according to Google Scholar.

Hence, her 9 years of work in the field had helped her build a formidable CV which was appreciated by the adjudicating bench as well who granted her the approval without an RFE. We are glad to have been of help to her in this process.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.